Cargando…

Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy

BACKGROUND: Cardiovascular disease (CVD) is the leading non-malignant cause of death in childhood cancer survivors. Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy. Anthracycline-mediated cardiac injury may lie latent for years following cessation of treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Treya M., Marsh, Channa E., Dembo, Lawrence G., Watson, Philip, Wallman, Karen E., Walwyn, Thomas S., Choong, Catherine S., Naylor, Louise H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048057/ https://www.ncbi.nlm.nih.gov/pubmed/32154017 http://dx.doi.org/10.1186/s40959-019-0047-4

Ejemplares similares

Exercise training improves vascular function and secondary health measures in survivors of pediatric oncology related cerebral insult
por: Long, Treya M., et al.
Publicado: (2018)

Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines
por: Franco, Vivian I., et al.
Publicado: (2011)

In vitro anthracycline cross-resistance pattern in childhood acute lymphoblastic leukaemia.
por: Klumper, E., et al.
Publicado: (1995)

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015)

Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy
por: Tham, Edythe B, et al.
Publicado: (2011)

Cardiac Events in Childhood Cancer Survivors Treated with Anthracyclines: The Value of Previous Myocardial Strain Measurement
por: Pourier, Milanthy, et al.
Publicado: (2022)

After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood
por: Scheede-Bergdahl, Celena, et al.
Publicado: (2013)

Strategies to Prevent Anthracycline-Related Congestive Heart Failure in Survivors of Childhood Cancer
por: Armenian, Saro H., et al.
Publicado: (2012)

Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
por: Li, Vivian Wing-yi, et al.
Publicado: (2018)

Evaluation of Cardiotoxic Effects of Anthracyclines by Tissue Doppler Imaging in Survivors of Childhood Cancer
por: Caliskan, Munise, et al.
Publicado: (2021)

CMR assessment of myocardial mechanics and tissue characterization in patients treated with Anthracycline chemotherapy for acute myeloid leukaemia
por: Miller, Christopher A, et al.
Publicado: (2012)

Mitochondrial apoptosis-related gene polymorphisms are associated with responses to anthracycline-based chemotherapy in acute myeloid leukaemia
por: Meng, Guangqiang, et al.
Publicado: (2023)

Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas.
por: Hawkins, M. M., et al.
Publicado: (1995)

Cancer in the offspring of survivors of childhood leukaemia and non-Hodgkin lymphomas.
por: Taylor, G. M.
Publicado: (1996)

Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
por: Wang, Yuehan, et al.
Publicado: (2023)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study
por: Leerink, Jan M., et al.
Publicado: (2022)

Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984)

Hypertension Susceptibility Loci are Associated with Anthracycline-related Cardiotoxicity in Long-term Childhood Cancer Survivors
por: Hildebrandt, Michelle A. T., et al.
Publicado: (2017)

Local arterial stiffness measured by ultrafast ultrasound imaging in childhood cancer survivors treated with anthracyclines
por: Rasouli, Rahna, et al.
Publicado: (2023)

Cardiotoxicity After Anthracycline Chemotherapy for Childhood Cancer in a Multiethnic Asian Population
por: Tan, Varen Zhi Zheng, et al.
Publicado: (2021)

Markers of infection, breast-feeding and childhood acute lymphoblastic leukaemia
por: Infante-Rivard, C, et al.
Publicado: (2000)

Asymptomatic systolic dysfunction on contemporary echocardiography in anthracycline-treated long-term childhood cancer survivors: a systematic review
por: Merkx, Remy, et al.
Publicado: (2021)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019)

Left ventricular dyssynchrony in long-term childhood cancer survivors treated with anthracyclines: a retrospective cross-sectional study
por: Pourier, Milanthy S., et al.
Publicado: (2021)

Exercise to Reduce Anthracycline-Mediated Cardiovascular Complications in Breast Cancer Survivors
por: Varghese, Sonu S., et al.
Publicado: (2021)

Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines
por: Mladosievicova, Beata, et al.
Publicado: (2012)

P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
por: Badiner, G. J., et al.
Publicado: (1990)

Dietary Intakes Are Associated with HDL-Cholesterol in Survivors of Childhood Acute Lymphoblastic Leukaemia
por: Morel, Sophia, et al.
Publicado: (2019)

Marrow relapse on maintenance chemotherapy in childhood acute lymphoblastic leukaemia.
por: Kearney, P. J., et al.
Publicado: (1979)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

Burden of chronic diseases among sarcoma survivors treated with anthracycline chemotherapy: results from an observational study
por: Baker, Laurence H., et al.
Publicado: (2020)

Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
por: Masood, Imran Ross, et al.
Publicado: (2023)

Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy
por: Sofia, Rosaria, et al.
Publicado: (2021)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

Study of cytochemical markers ACP and ANAE in childhood lymphoma and leukaemia.
por: Basso, G., et al.
Publicado: (1980)

Characterisation of anthracycline cardiotoxicity in long-term childhood cancer survivors using conventional and novel CMR techniques: probing the pathology
por: Quyam, Sadia, et al.
Publicado: (2015)

Neurofibromatosis and childhood leukaemia.
por: Zvulunov, A., et al.
Publicado: (1996)

Endurance versus resistance training in treatment of cardiovascular risk factors: A randomized cross-over trial
por: Thomas, Hannah J., et al.
Publicado: (2022)

Auxological changes in UK survivors of childhood acute lymphoblastic leukaemia treated without cranial irradiation
por: Breene, R A L, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_itpn5ce04ij0v10m76hsrmf0gd